HCW Biologics Stock (NASDAQ: HCWB) stock price, news, charts, stock research, profile.
Open | $1.530 |
Close | $1.590 |
Volume / Avg. | 2.723K / 16.795K |
Day Range | 1.500 - 1.590 |
52 Wk Range | 0.910 - 2.320 |
Market Cap | $68.460M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 0.07% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of HCW Biologics (NASDAQ: HCWB) through any online brokerage.
Other companies in HCW Biologics’s space includes: Kezar Life Sciences (NASDAQ:KZR), Vaxxinity (NASDAQ:VAXX), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Eagle Pharmaceuticals (NASDAQ:EGRX).
The latest price target for HCW Biologics (NASDAQ: HCWB) was reported by EF Hutton on Thursday, June 1, 2023. The analyst firm set a price target for 9.00 expecting HCWB to rise to within 12 months (a possible 397.24% upside). 2 analyst firms have reported ratings in the last year.
The stock price for HCW Biologics (NASDAQ: HCWB) is $1.81 last updated April 15, 2024 at 3:05 AM EDT.
There are no upcoming dividends for HCW Biologics.
HCW Biologics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for HCW Biologics.
HCW Biologics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.